Characteristics | N (%) |
---|---|
Time to onset (months): median (range) | 18 (4 - 58) |
Age (years): mean ± SD | 52 ± 12 |
Distribution | |
Lumbosacral | 6 (20.7) |
Thoracic or abdominal | 9 (31) |
Facial | 5 (17.2) |
Extremities | 4 (13.8) |
Visceral | 0 (0) |
Unknown | 5 (17.2) |
Hospital admission | |
No | 26 (89.7) |
Yes | 3 (10.3) |
Antiviral treatment | |
Valacyclovir | 11 (37.9) |
Acyclovir (i.v) | 2 (6.9) |
Acyclovir (p.o) | 12(41.4) |
Famciclovir | 2 (6.9) |
Unknown | 2 (6.9) |
Pre-transplant VZV disease | |
No | 2 (6.9) |
Yes | 27 (93.1) |
PHN | |
No | 15 (51.7) |
Yes | 14 (48.3) |